Read more

May 31, 2022
1 min read
Save

Exercise, drug sequence data top headlines for Osteoporosis Awareness Month

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In honor of Osteoporosis Awareness Month in May, advocacy organizations used social media to spread the word about the disease, including tips for patients on how to better manage their disease.

Information from the Bone Health and Osteoporosis Foundation include ways to exercise effectively, as well as data on the role bone mass plays in osteoporosis.

osteoporosis awareness graphic

In recognition of Osteoporosis Awareness Month, Healio has compiled five stories detailing news and updates regarding osteoporosis, osteoarthritis and other bone diseases. Read them below.

TPX-100 injection may ‘reduce or eliminate’ need for knee replacement in osteoarthritis

TPX-100, a novel intra-articular injection, yielded strong improvements in bone shape change and function that may ultimately minimize the need for knee replacement, according to a speaker at the 2022 OARSI World Congress. Read more.

Choice of osteoporosis drug sequence has ‘important clinical consequences’

Understanding when to switch from one class of drugs to another is critical to maintaining bone health and preventing fractures in osteoporosis, according to data presented at the Congress of Clinical Rheumatology East. Read more.

Walking, maximum-level activity reduce odds of cartilage loss in knee osteoarthritis

Increasing rates of walking, standing or maximum-level activity is associated with reductions in cartilage loss in knee osteoarthritis, according to a speaker at the 2022 OARSI World Congress. Read more.

Subcutaneous tanezumab, NSAIDs improve osteoarthritis pain

Tanezumab and NSAIDs both demonstrated early and sustained improvement in pain and function among patients with knee or hip osteoarthritis, according to data published in Arthritis Research and Therapy. Read more.

'No clinically relevant effect': Duloxetine fails to impact chronic osteoarthritis pain

Adding duloxetine to usual care fails to result in any “clinically relevant effect” in patients with chronic hip or knee osteoarthritis pain, compared with usual care alone, according to data published in Arthritis & Rheumatology. Read more.

Reference:

@bonehealthBHOF. https://twitter.com/bonehealthBHOF/status/1527763567805603842. May 20, 2022. Accessed May 24, 2022.